Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

NCT03897881

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • California Pacific Medical Center Research Institute -CPMCRI San Francisco, California, United States
  • Angeles Clinic and Research Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

NCT06784648

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +27 more
Locations
  • Charité - Universitatsmedizin Berlin Berlin, Germany
  • University Hospital Essen Essen, Germany
  • University Hospital Heidelberg Heidelberg, Germany
  • University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany
View Trial Details
Active, Not Recruiting

Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial

NCT05142241

Conditions
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, +8 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

NCT05973487

Conditions
Adnexal Diseases, Anogenital Cancers, Cervical Cancer, +47 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details

Related conditions